Chronic Rhinosinusitis Trial, Recruiting NCT06501807 Sponsor: University Hospital, Lille Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Chronic Rhinosinusitis Trial, Recruiting

NCT06501807
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and your doctor has recommended a biologic treatment (a type of medicine made from living cells) for a condition called chronic rhinosinusitis with nasal polyps (long-term blocked sinuses with growths inside the nose)
  • You may also be included if you have already been receiving this type of treatment since August 2021, as your past health records may be collected as part of the study

Who may not be able to join:

  • You have taken steroid tablets or liquid (such as prednisolone) by mouth in the past month
  • You have used certain biologic medicines — including omalizumab, mepolizumab, benralizumab, or dupilumab — or any similar medicine for an inflammatory condition in the past 6 months before starting this trial (unless you are currently using one of these medicines for severe asthma or nasal polyps)
  • You have had a known allergic reaction to humanised antibodies, which are a type of medicine used in biologic treatments (confirm with trial site)
  • You had a confirmed COVID-19 infection in the last 3 months and still have ongoing problems with your sense of smell because of it
  • You are currently pregnant or breastfeeding
  • You do not have social security or health insurance coverage (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0320445675

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 July 2024
Est. completion
2 September 2034

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Comparison of quality of life over 5 years according to the asthmatic status of the patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov